ARA-290

ARA-290, also known as Cibinetide, is an 11-amino acid peptide that is derived from the beta-helix region of erythropoietin. This compound has been the focus of extensive research due to its potential non-hematopoietic functions. ARA-290 is primarily studied for its tissue-protective and anti-inflammatory properties, making it a candidate for various therapeutic applications.

Research indicates that ARA-290 may play a significant role in modulating inflammatory responses and promoting cellular protection in various models of injury and disease. Its mechanism of action involves the inhibition of pro-inflammatory pathways, which can lead to reduced tissue damage and improved recovery outcomes in preclinical studies.

In addition to its anti-inflammatory effects, ARA-290 has shown promise in enhancing tissue repair and regeneration. This has implications for research in fields such as neurology, cardiology, and regenerative medicine, where inflammation and tissue damage are critical factors in disease progression and recovery.

For research and laboratory use only. Not for human consumption.